Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 21, 2023; 29(7): 1219-1234
Published online Feb 21, 2023. doi: 10.3748/wjg.v29.i7.1219
Published online Feb 21, 2023. doi: 10.3748/wjg.v29.i7.1219
Ref. | Country | Age (yr) | No. cases (M/W), endpoint | No. controls, type | Gene (SNP) | Nutrient/alcohol | Method for measuring nutrition intake | Outcome (OR, 95%CI) | Adjustments to OR | NOS | ||
SNP | Nutrient/alcohol | Interaction | ||||||||||
Chen et al[23] | United States | 40-75 | 144 M, CRC | 627 C | MTHFR (677C>T) | Dietary folate, Met, and alcohol | Validated FFQ (self-reported) | No assoc | Alcohol (≥ 5 vs ≤ 1 drinks/wk): 1.61 (1.01-2.58) | 677TT (vs CC/CT)-low alcohol consumption (≤ 1 drinks/wk): 0.11 (0.01-0.85) (P-interac = 0.02) | Age, CRC family history | 7 |
Guerreiro et al[24] | Portugal | Cases (64.2 ± 11.3), controls (62.2 ± 12.1) | 104/92 CRC | 200 C | MTHFR (677C>T), MS (2756A>G), SHMT (1420C>T) | Dietary folate, vitamins B6 and B12, glycine, Met, serine, and alcohol | Validated FFQ (by interview) | 677TT (vs CC/CT): 3.01, (1.3-6.7); 1420TT (vs CC/CT): 2.6, (1.1-5.9) | Folate (> 406.7 mcg/d vs < 406.7 mcg/d): 0.67 (0.45-0.99) | 677TT (vs CC/CT)– folate (< 406.7 mcg/d): 14.0, 1.8-108.5 (P = 0.05) | Age, CRC history, and sex | 5 |
Kim et al[25] | Korea | 30-79 | 465/322 CRC (363 CCa, 330 RCa) | 656 H | MTHFR(677C>T) | Dietary folate and alcohol | Validated FFQ | 677TT (vs CC/CT): 0.60 (0.46-0.78) | Folate (high vs low intake): 0.64 (0.49-0.84); alcohol (high vs low intake): 1.76 (1.26-2.46) | 677CC/CT–Low-methyl diet (folate < 209.69 mcg/d and alcohol ≥ 30 g/d): 2.32 (1.18-4.56) (P-interac = no assoc) | Age, BMI, CRC family history, energy intake, multivitamin use, sex, smoking status | 7 |
Ma et al[26] | United States | 40-84 | 202 M, CRC | 326 C | MTHFR (677C>T) | Plasma folate, and alcohol consumption | FFQ (self-reported) | 677TT (vs CC): 0.45 (0.24-0.86) | Folate (plasma deficiency vs adequate levels): No assoc | 677TT (vs TC/CC)–folate (adequate levels): 0.32 (0.15-0.68) | Age, alcohol consumption, aspirin use, BMI, exercise, multivitamin use, and smoking status | 7 |
Alcohol: Unk | 677TT (vs CC)–alcohol (0-0.14 drinks/d): 0.12 (0.03-0.57) | Age | ||||||||||
Murtaugh et al[27] | United States | 30-79 | 446/305 RCa | 979 C | MTHFR (677C>T, 1298A>C) | Dietary folate, riboflavin, vitamins B6 and B12, Met, and alcohol | FFQ (by interview) | W, 677TT (vs CC): 0.54 (0.30-0.98). M&W, 1298CC (vs AA): 0.67 (0.46-0.98) | Dietary folate (> 475 mcg/d vs < = 322 mcg/d): 0.66 (0.48-0.92). High methyl donor status (vs low status): 0.79 (0.66-0.95) | No assoc | Age, BMI, ibuprofen use, intake of energy, fibre and calcium, PA, sex, and smoking status | 6 |
Pufulete et al[28] | United Kingdom | 38-90 | 13/15 CRC | 76 C | MTHFR (677C>T, 1298A>C), MS (2756A>G), CBS (844ins68) | Plasma folate, vitamin B12, and homocysteine, alcohol and folate intake | Validated FFQ (by interview) | 677TT (vs CC): 5.98 (0.92-38.66), P = 0.06; 1298CC (vs AA): 12.6 (1.12-143.70), P = 0.04 | Folate status score (T3 vs T1): 0.09 (0.01-0.57), P-trend = 0.01 | Unk | Age, alcohol consumption, BMI, sex, and smoking status | 7 |
Sharp et al[29] | United Kingdom | 150/114 (189 CCa, 75 RCa) | 408C | MTHFR (677C>T, 1298A>C) | Dietary folate, riboflavin, vitamins B6 and B12, and alcohol | Validated FFQ (self-reported) | No assoc | No assoc | 677CT/TT (vs CC)–folate (> mean): P-interac = 0.029. 677CT/TT (vs CC)–vitamin B6 (> mean): P-interac = 0.016 | Age, CRC family history, energy intake, NSAID use, PA, and sex | 6 | |
Slattery et al[30] | United States | 30-79 | 824/849 CC (DCCa 405/303; PCCa 395/327) | 1816 C | MTHFR (677C>T) | Dietary folate, Met, vitamins B6 and B12, and alcohol | Validated CARDIA diet questionnaire | 677TT: No assoc | Unk | TT-low risk diet (high in folate and Met and without alcohol): 0.4 (0.1-0.9) | Age, BMI, intake of energy and fibre, PA, and smoking intensity | 7 |
- Citation: Chávez-Hidalgo LP, Martín-Fernández-de-Labastida S, M de Pancorbo M, Arroyo-Izaga M. Influence of methyl donor nutrients as epigenetic regulators in colorectal cancer: A systematic review of observational studies. World J Gastroenterol 2023; 29(7): 1219-1234
- URL: https://www.wjgnet.com/1007-9327/full/v29/i7/1219.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i7.1219